Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Journal of Translational Medicine|July 10, 2012
Clinical evaluation of a matrix metalloproteinase-12 cleaved fragment of titin as a cardiovascular serological biomarkerEfstathios Vassiliadis, Lars M Rasmussen, Inger Byrjalsen, et al.
The American Journal of Gastroenterology|November 30, 2020
A Sequential Algorithm Combining ADAPT and Liver Stiffness Can Stage Metabolic-Associated Fatty Liver Disease in Hospital-Based and Primary Care PatientsMohammed Eslam, Grace Lai-Hung Wong, Ahmed M Hashem, et al.
JCI Insight|March 10, 2025
Leveraging complementary multi-omics data integration methods for mechanistic insights in kidney diseasesFadhl Alakwaa, Vivek Das, Arindam Majumdar, et al.
Kidney International|May 26, 2022
Results of untargeted analysis using the SOMAscan proteomics platform indicates novel associations of circulating proteins with risk of progression to kidney failure in diabetesHiroki Kobayashi, Helen C Looker, Eiichiro Satake, et al.
American Journal of Translational Research|November 13, 2012
Circulating levels of citrullinated and MMP-degraded vimentin (VICM) in liver fibrosis related pathologyEfstathios Vassiliadis, Claudia P Oliveira, Mario R Alvares-da-Silva, et al.
Physiological Genomics|September 19, 2019
Associations of osteopontin and NT-proBNP with circulating miRNA levels in acute coronary syndromeLydia Coulter Kwee, Megan L Neely, Elizabeth Grass, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 27, 2018
JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trialKatherine R Tuttle, Frank C Brosius, Sharon G Adler, et al.
Diabetes Care|July 8, 2018
Validation of Plasma Biomarker Candidates for the Prediction of eGFR Decline in Patients With Type 2 DiabetesAndreas Heinzel, Michael Kammer, Gert Mayer, et al.
Nature Communications|February 7, 2026
Urinary clusterin as a biomarker of human kidney disease progression and response to the endothelin receptor antagonist atrasentan: An exploratory analysis from the SONAR trialWenjun Ju, Viji Nair, Priya Vart, et al.
Kidney International|November 5, 2019
Integrative analysis of prognostic biomarkers derived from multiomics panels helps discrimination of chronic kidney disease trajectories in people with type 2 diabetesMichael Kammer, Andreas Heinzel, Jill A Willency, et al.
Pageof 5